| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.012 | 1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |